Literature DB >> 32415789

Intermittent hypercapnic hypoxia induces respiratory hypersensitivity to fentanyl accompanied by tonic respiratory depression by endogenous opioids.

Allison D Brackley1,2, Mary Ann Andrade1, Glenn M Toney1,2.   

Abstract

KEY POINTS: Sleep apnoea increases susceptibility to opioid-induced respiratory depression (OIRD). Endogenous opioids are implicated as a contributing factor in sleep apnoea. Rats exposed to sleep-phase chronic intermittent hypercapnic hypoxia (CIHH) for 7 days exhibited exaggerated OIRD to systemic fentanyl both while anaesthetized and artificially ventilated and while conscious and breathing spontaneously, implicating heightened CNS inhibitory efficacy of fentanyl. CIHH also induced tonic endogenous opioid suppression of neural inspiration. Sleep-related episodes of hypercapnic hypoxia, as in sleep apnoea, promote hypersensitivity to OIRD, with tonic respiratory depression by endogenous opioids implicated as a potential underlying cause. ABSTRACT: Sleep apnoea (SA) increases opioid-induced respiratory depression (OIRD) and lethality. To test the hypothesis that this results from chronic intermittent bouts of hypercapnic hypoxia (CIHH) accompanying SA, we compared OIRD across continuously normoxic control rats and rats exposed to sleep-phase (8 h/day) CIHH for 1 week. OIRD sensitivity was first assessed in anaesthetized (urethane/α-chloralose), vagotomized and artificially ventilated rats by recording phrenic nerve activity (PNA) to index neural inspiration and quantify PNA burst inhibition to graded doses (0, 2, 20, 50 μg kg-1 , i.v.) of the synthetic opioid fentanyl. Fentanyl dose-dependently reduced PNA burst frequency (P = 0.0098-0.0001), while increasing the duration of burst quiescence at 50 μg kg-1 (P < 0.0001, n = 5-6/group/dose). CIHH shifted the fentanyl dose-phrenic burst frequency response curve to the left (P = 0.0163) and increased the duration of burst quiescence (P < 0.0001). During fentanyl recovery, PNA burst width was increased relative to baseline in normoxic and CIHH rats. Systemic naloxone (1 mg kg-1 , i.v.) reversed fentanyl-induced PNA arrest in both groups (P = 0.0002), and increased phrenic burst amplitude above baseline (P = 0.0113) in CIHH rats only. Differential sensitivity to anaesthesia as a cause of CIHH-related OIRD hypersensitivity was excluded by observing in conscious spontaneously breathing rats that fentanyl at 20 μg kg-1 (i.v.), which silenced PNA in anaesthetized rats, differentially increased breathing variability in normoxic versus CIHH rats (P = 0.0427), while significantly reducing breathing frequency (P < 0.0001) and periodicity (P = 0.0003) in CIHH rats only. Findings indicate that CIHH increased OIRD sensitivity, with tonic inspiratory depression by endogenous opioids as a likely contributing cause.
© 2020 The Authors. The Journal of Physiology © 2020 The Physiological Society.

Entities:  

Keywords:  opioid induced respiratory depression; opioids; sleep apnoea

Mesh:

Substances:

Year:  2020        PMID: 32415789      PMCID: PMC8162062          DOI: 10.1113/JP280021

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  56 in total

Review 1.  Modeling the ponto-medullary respiratory network.

Authors:  I A Rybak; N A Shevtsova; J F R Paton; T E Dick; W M St-John; M Mörschel; M Dutschmann
Journal:  Respir Physiol Neurobiol       Date:  2004-11-15       Impact factor: 1.931

2.  Delayed muscular rigidity and respiratory depression following fentanyl anesthesia.

Authors:  J M Klausner; J Caspi; S Lelcuk; A Khazam; G Marin; H B Hechtman; R R Rozin
Journal:  Arch Surg       Date:  1988-01

3.  Combined hypoxia and hypercapnia, but not hypoxia alone, suppresses neurotransmission from orexin to hypothalamic paraventricular spinally-projecting neurons in weanling rats.

Authors:  Olga Dergacheva; David Mendelowitz
Journal:  Brain Res       Date:  2017-11-21       Impact factor: 3.252

4.  Effect of treatment with nasal continuous positive airway pressure on ventilatory response to hypoxia and hypercapnia in patients with sleep apnea syndrome.

Authors:  Lucia Spicuzza; Luciano Bernardi; Rossella Balsamo; Nicola Ciancio; Riccardo Polosa; Giuseppe Di Maria
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

Review 5.  The chemoreflex control of breathing and its measurement.

Authors:  J Duffin
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

6.  Chemoreflex control of ventilation is altered during wakefulness in humans with OSA.

Authors:  Jason H Mateika; Marzouk Ellythy
Journal:  Respir Physiol Neurobiol       Date:  2003-10-16       Impact factor: 1.931

7.  Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure.

Authors:  E C Fletcher; G Bao; C C Miller
Journal:  J Appl Physiol (1985)       Date:  1995-04

8.  Increased CSF opioid activity in sleep apnea syndrome. Regression after successful treatment.

Authors:  T Gislason; M Almqvist; G Boman; C E Lindholm; L Terenius
Journal:  Chest       Date:  1989-08       Impact factor: 9.410

9.  Discharge patterns of bulbar respiratory neurons in response to the morphinomimetic agent, fentanyl, in chloralosed dogs.

Authors:  M Laubie; M Drouillat; H Schmitt
Journal:  Eur J Pharmacol       Date:  1986-04-02       Impact factor: 4.432

10.  Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database.

Authors:  Barbara K Zedler; William B Saunders; Andrew R Joyce; Catherine C Vick; E Lenn Murrelle
Journal:  Pain Med       Date:  2018-01-01       Impact factor: 3.750

View more
  2 in total

1.  Oxytocin Receptor Activation Rescues Opioid-Induced Respiratory Depression by Systemic Fentanyl in the Rat.

Authors:  Allison Doyle Brackley; Glenn M Toney
Journal:  J Pharmacol Exp Ther       Date:  2021-05-14       Impact factor: 4.402

2.  Local ionotropic glutamate receptors are required to trigger and sustain ramping of sympathetic nerve activity by hypothalamic paraventricular nucleus TNFα.

Authors:  Aline A Mourão; Caroline G Shimoura; Mary Ann Andrade; Tamara T Truong; Gustavo R Pedrino; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-06       Impact factor: 5.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.